Skip to main content
. 2013 Oct 21;13:487. doi: 10.1186/1471-2407-13-487

Figure 5.

Figure 5

Overall survival (OAS) and disease-free survival (DFS) for TNBC patients who received 100% guideline-adherent adjuvant treatment, as stratified by age (<50 n = 164; 50–64 n = 134; ≥65 n = 73) and adjusted for year of diagnosis, tumor size, grading, nodal status, menopausal status, and comorbidities.